Vestibular Neuritis Clinical Trial
Official title:
Which Treatment is Most Effective When Treating Vestibular Neuritis: Corticosteroid Treatment Alone or Combined Corticosteroid Treatment and Vestibular Rehabilitation?
Verified date | July 2022 |
Source | Aalborg University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To investigate which treatment option (corticosteroid treatment alone or combined corticosteroid treatment and vestibular rehabilitation) is the most effective in patients diagnosed with vestibular neuritis.
Status | Completed |
Enrollment | 50 |
Est. completion date | January 1, 2022 |
Est. primary completion date | July 1, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Age above 18 years of age 2. Medical history compatible with vestibular neuritis 3. Verification of vestibular neuritis with positive romberg test, pathological v-HIT and horizontal nystagmus with a rotatory component. Exclusion Criteria: 1. Former medical history with vestibular dysfunction 2. Medical history or objective signs of cochlear dysfunction before, during or after onset of vestibular neuritis 3. Onset of symptoms 14 days before recruitment to the study 4. Focal neurological symptoms/signs 5. Contraindication to prednisolone treatment 6. Problem with participating in vestibular rehabilitation due to muscular-skeletal disease ect. |
Country | Name | City | State |
---|---|---|---|
Denmark | Department of Otolaryngology, Head & Neck Surgery and Audiology | Aalborg | North Denmark Region |
Lead Sponsor | Collaborator |
---|---|
Aalborg University Hospital |
Denmark,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Suppressing head impulse paradigm (SHIMP) | SHIMP equipment will objectively quantify change of vestibular function. | 6 month | |
Primary | Subjective visual vertical (SVV) | SVV test will objectively quantify the experienced spatial orientation as an indicator of visual and vestibular otolithic function | 6 month | |
Primary | Video head impulse test (v-HIT) | v-HIT equipment will objectively quantify change of vestibular function. | 6 month | |
Primary | Dizziness handicap inventory (DHI) questionnaire | Fulfillment of the questionnaire "Dizziness Handicap Inventory" (DHI) will quantify the level of experienced vertigo. | 6 month |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02655575 -
Assessment and Treatment of Patients With Long-term Dizziness in Primary Care
|
N/A | |
Completed |
NCT05157399 -
Quantification of the Effect of the OtoBand on Objective Measures of Vertigo and Dizziness
|
N/A | |
Completed |
NCT02098330 -
The Efficacy of Steroid Therapy in Vestibular Neuritis
|
Phase 3 | |
Recruiting |
NCT04678167 -
Boarding Ring Glasses Versus Placebo Glasses or Not Glasses in the Treatment of Vestibular Neuritis
|
N/A | |
Not yet recruiting |
NCT05424302 -
Effect of Peripheral Vestibular Disease Location on Outcomes Following Home-based Virtual Reality Vestibular Therapy
|
N/A | |
Recruiting |
NCT01231009 -
The Role of Corticosteroids and Vestibular Exercises in Recovery of Vestibular Neuritis
|
Phase 0 | |
Completed |
NCT03452410 -
MRIPositive Diagnosis of Vestibular Neuritis Using Fluid Attenuated Inversion Recuperation (FLAIR) Sequence on a 1.5 Tesla
|
||
Recruiting |
NCT04926363 -
Prevalence of Cardiovascular Risk Factors in Upper Vestibular Neuritis
|
||
Recruiting |
NCT04935970 -
Metabolic Disorders and Vertigo
|
||
Completed |
NCT02171312 -
Clinical Evaluation of a Novel Balance, Vestibular and Oculomotor Assessment Tool
|
N/A |